NOVELIX PHARMACEUTICALS LIMITE Share Price

₹ 66.00

-₹2.57 (-3.75%)
1D
Last updated 02 Nov, 2026, 15:25 IST
BSE: 536565
|
Trading

NOVELIX PHARMACEUTICALS LIMITE Share Price Today

As of 2 Nov 2026, NOVELIX PHARMACEUTICALS LIMITE share price is ₹66.00. The stock opened at ₹68.00, compared to its previous close of ₹68.57. During today's trading session, NOVELIX PHARMACEUTICALS LIMITE share price moved in the range of ₹58.00 to ₹69.75, with an average price of ₹63.88 for the day. Looking at its last 52-week, the stock has touched a low of ₹49.01 and a high of ₹92.00.

Share price over the last 1 day fell from 66.20 to 66.00, ranging between 58.00 and 69.75.
₹58.00
3.75% down today
₹69.75
1D LOW
1D HIGH

NOVELIX PHARMACEUTICALS LIMITE Stock Insights

Latest Earning
Op Profit TrendUp by 45.87% YoY
Latest Earning
Net Profit TrendUp by 46.01% YoY
Latest Earning
Revenue TrendDown by 8.45% QoQ
Stock Performance
OutperformingBeat Nifty by 4.14 % in last 3 month
NOVELIX PHARMACEUTICALS LIMITE stock performance
Open₹68.00
High₹69.75
Low₹58.00
Prev. close₹68.57
NOVELIX PHARMACEUTICALS LIMITE trading activity
Volume875
Average traded price₹67.58
Last traded time03:25:06 02 Nov
Last traded quantity100
Circuit
L
H
₹54.86
₹82.28
52-week
L
H
₹49.01
₹92.00
Mkt Cap Cr
58.64
P/E
-27.0
P/B
3.24
ROA
-30.18%
ROE
-30.18%
ROCE
-32.45%
Quick Ratio
5.31
EV/EBITDA
-23.57

Based on fundamentals, this stock's

Performance: 3 out of 5, Neutral
Performance
Neutral
Novelix Pharma. performance is moderate compared to markets
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Novelix Pharma. appears overvalued compared to its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
Novelix Pharma. earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,76,306.2184.09.64.7%11.42%11.37%0.7533.6
Laurus Labs1,29,242.6897.021.3311.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

NOVELIX PHARMACEUTICALS LIMITE Company Background

ISIN
INE314I01036
Sector Market Cap
₹ 58.64 Cr

Novelix Pharmaceuticals Ltd, formerly Trimurthi Limited, is an India-based company, which is engaged in the business of trading pharmaceuticals and related products and is in the business of trading shares and securities. The Company's segments include Pharma Business, Investment is Shares, Trading in shares, Foods, and Finance.

NOVELIX PHARMACEUTICALS LIMITE Financial Highlights

  • Revenue: NOVELIX PHARMACEUTICALS LIMITE reported revenue of ₹9.16 crore in FY22 vs ₹9.58 crore in FY21. It showed a decrease of 4.38% on a yearly basis.
  • Operating Profit: NOVELIX PHARMACEUTICALS LIMITE reported an operating loss of ₹2.03 crore in FY22 vs ₹3.75 crore in FY21. It showed an increase of 45.87% on a year-on-year basis.
  • Net Profit: NOVELIX PHARMACEUTICALS LIMITE reported a net loss of ₹2.03 crore in FY22 vs ₹3.76 crore in FY21. It showed an increase of 46.01% on a yearly basis.

NOVELIX PHARMACEUTICALS LIMITE Quarterly Result Highlights

  • NOVELIX PHARMACEUTICALS LIMITE reported revenue of ₹36.91 crore in Jun 2026, compared with ₹25.19 crore in Mar 2026, representing an increase of 46.53% on a quarter-on-quarter (QoQ) basis.
  • NOVELIX PHARMACEUTICALS LIMITE reported an operating profit of ₹1.12 crore in Jun 2026, compared with ₹1.23 crore in Mar 2026, representing a decrease of 8.94% on a quarter-on-quarter (QoQ) basis.
  • NOVELIX PHARMACEUTICALS LIMITE reported a profit of ₹1.18 crore in Jun 2026, compared with ₹0.91 crore in Mar 2026, reflecting an increase of 29.67% on a QoQ basis.
  • The earnings per share (EPS) of NOVELIX PHARMACEUTICALS LIMITE stood at ₹1.21 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
54.29%
FII
0.00%
Other DII
0.00%
Retail and other
45.71%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Mar 20260.00%
Jun 20260.00%
Jul 20260.00%
Sep 20260.00%

NOVELIX PHARMACEUTICALS LIMITE Investment Returns

1 day
-3.68%
1 week
+15.17%
1 month
-2.04%
1 year
+27.98%
3 years
+725.15%
5 years
+852.36%

NOVELIX PHARMACEUTICALS LIMITE Share Price History

NOVELIX PHARMACEUTICALS LIMITE share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
30 Oct 26
₹71.00 / ₹68.57
-3.68%
29 Oct 26
₹58.80 / ₹71.19
+15.93%
28 Oct 26
₹60.00 / ₹61.41
+2.30%
27 Oct 26
₹59.00 / ₹60.03
+1.40%
Show more

NOVELIX PHARMACEUTICALS LIMITE Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Revenue₹8.61₹9.24₹10.24₹9.89
Other Income₹0.55₹0.34₹0.60₹0.95
Total Revenue₹9.16₹9.59₹10.85₹10.84
Total Expenses₹11.23₹10.35₹11.06₹10.96
Profit Before Tax-₹2.03-₹3.75-₹0.21-₹0.12
Tax-₹0.01₹0.01₹0.04₹0.02
Profit After Tax-₹2.03-₹3.76-₹0.26-₹0.15
EPS - Basic-₹2.22-₹4.62-₹0.35-₹0.30
EPS - Diluted-₹2.22-₹4.62-₹0.35-₹0.30

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Profit before tax-₹2.12-₹3.73-₹0.21-₹0.12
Income before WC changes₹0.01-₹3.80-₹0.41-₹0.16
Change in Assets₹2.21₹5.02₹0.25-₹0.31
Change in Liabilities-₹1.11₹0.39₹0.90-₹0.06
Change in WC₹1.09₹5.42₹1.15-₹0.37
Cash flow from Operations₹1.59₹1.59₹0.63-₹0.53
Cash flow from Investing-₹0.76₹0.14₹0.45₹0.43
Cash flow from Financing₹0.00-₹0.77-₹0.16-₹0.05
Total Cash Flow₹0.83₹0.96₹0.92-₹0.15
Cash (Start of the year)₹2.06₹1.12₹0.20₹0.35
Cash (End of the year)₹2.89₹2.08₹1.12₹0.20

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Non-Current Assets₹2.81₹2.24₹2.33₹2.62
Current Assets₹5.93₹7.33₹11.39₹10.72
Total Assets₹8.74₹9.57₹13.72₹13.34
Current Liabilities₹0.93₹2.18₹1.81₹0.99
Net Current Asset₹5.00₹5.16₹9.58₹9.73
Non-Current Liabilities₹0.13₹0.03₹0.79₹0.93
Equity Capital₹7.68₹7.37₹11.13₹11.42
Total Equity & Liabilities₹8.74₹9.57₹13.72₹13.34

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹132.31₹30.72₹4.22₹1.40
Other Income₹0.03₹0.02₹0.31₹0.52
Total Revenue₹132.34₹30.73₹4.53₹1.92
Total Expenses₹128.93₹30.61₹4.51₹1.98
Profit Before Tax₹3.40₹0.12₹0.02-₹0.06
Tax₹0.85₹0.04₹0.01₹0.00
Profit After Tax₹2.56₹0.08₹0.01-₹0.06
EPS - Basic₹1.21₹0.08₹0.01-₹0.07
EPS - Diluted₹1.75₹0.09₹0.01-₹0.07

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹3.40₹0.12₹0.02-₹0.06
Income before WC changes₹3.47₹0.15-₹0.25-₹0.52
Change in Assets-₹57.22-₹22.24-₹0.04-₹1.94
Change in Liabilities₹31.36₹8.41-₹0.05₹0.05
Change in WC-₹25.86-₹13.83-₹0.10-₹1.89
Cash flow from Operations-₹22.39-₹13.68-₹0.34-₹2.41
Cash flow from Investing-₹1.72₹2.93₹0.19₹0.08
Cash flow from Financing₹26.39₹11.32₹0.00₹0.00
Total Cash Flow₹2.28₹0.56-₹0.16-₹2.33
Cash (Start of the year)₹0.68₹0.12₹0.27₹2.60
Cash (End of the year)₹2.96₹0.68₹0.12₹0.27

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹3.51₹0.27₹3.24₹3.01
Current Assets₹88.91₹26.93₹4.13₹4.24
Total Assets₹92.42₹27.21₹7.36₹7.26
Current Liabilities₹45.93₹9.67₹0.01₹0.06
Net Current Asset₹42.98₹17.27₹4.12₹4.18
Non-Current Liabilities₹0.00₹0.00₹0.00₹0.00
Equity Capital₹46.49₹17.54₹7.35₹7.20
Total Equity & Liabilities₹92.42₹27.21₹7.36₹7.26
* All values are in INR Crore
NOVELIX PHARMACEUTICALS LIMITE market depth
Bid quantityBid priceAsk priceAsk quantity
0000
0000
0000
0000
0000
Total bid quantity0
Total ask quantity0
NOVELIX PHARMACEUTICALS LIMITE technical summary
Bearish indicators4
Neutral indicators3
Bullish indicators1
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
53.41
Neutral
ATR (14)
6.32
Neutral
STOCH(9,6)
81.08
Bearish
STOCH RSI (14)
82.54
Bearish
ADX(9)
45.68
Bearish
UO(9)
69.38
Neutral
ROC(12)
7.01
Bullish
WillR(14)
-19.06
Bearish
Period
Simple value
Exponential vaue
5D
64.08
65.79
10D
63.29
64.72
20D
64.98
65.77
50D
72.18
69.02
100D
73.08
69.32
Volume trend — traded volume by day
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct0L
26 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

NOVELIX PHARMACEUTICALS LIMITE
Trading
Add Stock
Add Another

NOVELIX PHARMACEUTICALS LIMITE Returns Calculator

Top Gainers

ITI Share Price
₹259.14
+43.19 (+20%)
ENGINERSIN Share Price
₹289.65
+37.8 (+15.01%)
AFFLE Share Price
₹1506.50
+164.7 (+12.27%)
PRAJIND Share Price
₹271.13
+29.43 (+12.18%)
DIXON Share Price
₹12319.00
+1319 (+11.99%)
See more

Top Losers

INDIGOPNTS Share Price
₹870.00
-127.3 (-12.76%)
CLEAN Share Price
₹662.60
-53 (-7.41%)
ZEEL Share Price
₹61.58
-4.82 (-7.26%)
SYRMA Share Price
₹1512.00
-113.3 (-6.97%)
POLICYBZR Share Price
₹931.00
-69.1 (-6.91%)
See more

NOVELIX PHARMACEUTICALS LIMITE Share Price FAQs

Please be aware that NOVELIX PHARMACEUTICALS LIMITE stock prices are subject to continuous fluctuations due to various factors.